Effects of Single Treatment of Anti-Dementia Drugs on Sleep-Wake Patterns in Rats
![]() ![]() |
Jung, Ji-Young
(Department of Pharmacology, School of Medicine, Kyungpook National University)
Roh, Moo-Taek (Department of Pharmacology, School of Medicine, Kyungpook National University) Ko, Kyung-Kyun (Department of Neurology, School of Medicine, Kyungpook National University) Jang, Hwan-Soo (Department of Pharmacology, School of Medicine, Kyungpook National University) Lee, Seong-Ryong (Department of Pharmacology, School of Medicine, Keimyung University) Ha, Jeoung-Hee (Department of Pharmacology, School of Medicine, Kyungpook National University) Jang, Il-Sung (Brain Science and Engineering Institute, Kyungpook National University) Lee, Ho-Won (Department of Neurology, School of Medicine, Kyungpook National University) Lee, Maan-Gee (Department of Pharmacology, School of Medicine, Kyungpook National University) |
1 | Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging. 2004;21:453-478. DOI ScienceOn |
2 | Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998;158:1021-1031. DOI ScienceOn |
3 | Stahl SM, Markowitz JS, Papadopoulos G, Sadik K. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. Curr Med Res Opin. 2004;20:517-524. DOI ScienceOn |
4 | Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Dis Assoc Disord. 2005;19:240-245. DOI ScienceOn |
5 | Schredl M, Weber B, Leins ML, Heuser I. Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons. Exp Gerontol. 2001;36:353-361. DOI ScienceOn |
6 | Guay DR. Drug forecast: memantine, prototype of a new approach to treatment of dementia. Consult Pharm. 2003;18:625-634. |
7 | Ishida T, Kamei C. Characteristic effects of anti-dementia drugs on rat sleep patterns. J Pharmacol Sci. 2009;109:449-455 DOI ScienceOn |
8 | Ishida T, Obara Y, Kamei C. Studies on wakefulness-promoting effect of memantine in rats. Behav Brain Res. 2010;206:274-278. DOI ScienceOn |
9 | Jung JY. Characterization of vibration signal patterns for rat behaviors using specially designed vibration sensors, Kyungpook National University Graduate School. 2010; MS Thesis. |
10 | Kwon DH, Won SH, Kim KM, Chang SM, Kim SH, Lee MG. Effect of caffeine on sleep and EEG spectra in rats. J Korean Soc Biol Ther Psychiatry. 2006;12:252-267. |
11 | Lee MG, Kim M, Roh M, Jang IS, Won SH. Differences between physostigmine- and yohimbine-induced states are visualized in canonical space constructed from EEG during natural sleepwake cycle in rats. Exp Neurobiol. 2011;20:54-65. DOI |
12 | Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer's disease. Am J Med. 2007;120:388-397. DOI ScienceOn |
13 | Blesa R. Galantamine: therapeutic effects beyond cognition. Dement Geriatr Cogn Disord. 2000;11 Suppl 1:28-34. DOI |
14 | Yesavage JA, Friedman L, Ancoli-israel S, Bliwise D, Singer C, Vitiello MV, Monjan AA, Lebowitz B. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol. 2003;16:131-139. DOI ScienceOn |
15 | Geerts H. Indicators of neuroprotection with galantamine. Brain Res Bull. 2005;64:519-524. DOI ScienceOn |
16 | Hanania T, Zahniser NR. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcohol Clin Exp Res. 2002;26:431-440. DOI ScienceOn |
17 | Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med. 2007;8 Suppl 4:S27-34. |
18 | Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institutionalization for people with dementia living at home with a carer. Int J Geriatr Psychiatry. 1998;13:682-690. DOI ScienceOn |
19 | Thompson S, Lanctôt KL, Herrmann N. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert Opin Drug Saf. 2004;3:425-440. DOI ScienceOn |
![]() |